{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T07:23:23Z","timestamp":1777361003090,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004045","name":"Karadeniz Teknik Universitesi","doi-asserted-by":"publisher","award":["TYL-2023-10681"],"award-info":[{"award-number":["TYL-2023-10681"]}],"id":[{"id":"10.13039\/501100004045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.taap.2024.117120","type":"journal-article","created":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T21:35:03Z","timestamp":1728250503000},"page":"117120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Fosaprepitant improves cyclophosphamide-induced bladder damage by alleviating inflammatory response in mice"],"prefix":"10.1016","volume":"492","author":[{"given":"Yaren","family":"Yesilbas Aksel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif Nur","family":"Barut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seckin","family":"Engin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.taap.2024.117120_bb0005","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1476-5381.1994.tb14845.x","article-title":"Characterization of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder","volume":"111","author":"Ahluwalia","year":"1994","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.taap.2024.117120_bb0010","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1086\/374749","article-title":"Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling","volume":"187","author":"Akira","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.taap.2024.117120_bb0015","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/iju.14229","article-title":"Interstitial cystitis\/bladder pain syndrome: the evolving landscape, animal models and future perspectives","volume":"27","author":"Akiyama","year":"2020","journal-title":"Int. J. Urol."},{"issue":"2","key":"10.1016\/j.taap.2024.117120_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0306-3623(96)00482-X","article-title":"The NK1 antagonist GR203040 inhibits cyclophosphamide-induced damage in the rat and ferret bladder","volume":"29","author":"Alfieri","year":"1997","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.taap.2024.117120_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108604","article-title":"Icariin attenuates cyclophosphamide-induced cystitis via down-regulation of NF-\u043aB and up-regulation of Nrf-2\/HO-1 signaling pathways in mice model","volume":"106","author":"Amanat","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2024.117120_bb0030","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3389\/fphar.2020.01305","article-title":"Characterization and validation of a chronic model of cyclophosphamide-induced interstitial cystitis\/bladder pain syndrome in rats","volume":"11","author":"Auge","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.taap.2024.117120_bb0035","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.urology.2007.11.012","article-title":"Effects of ischemia on tachykinin-containing nerves and neurokinin receptors in the rabbit bladder","volume":"71","author":"Azadzoi","year":"2008","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.taap.2024.117120_bb0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1124\/jpet.102.043539","article-title":"Neurokinin-1 receptor antagonists CP-96,345 and L-733,060 protect mice from cytokine-mediated liver injury","volume":"305","author":"Bang","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.taap.2024.117120_bb0045","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11255-019-02128-y","article-title":"Uroprotective effect of ambroxol in cyclophosphamide-induced cystitis in mice","volume":"51","author":"Barut","year":"2019","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.taap.2024.117120_bb0050","article-title":"Riluzole, a neuroprotective agent, preserves erectile function following bilateral cavernous nerve injury in male rats","author":"Barut","year":"2023","journal-title":"Int. J. Impot. Res."},{"issue":"4","key":"10.1016\/j.taap.2024.117120_bb0055","first-page":"404","article-title":"The role of toll-like receptors (TLRs) in urinary tract infections (UTIs)","volume":"69","author":"Behzadi","year":"2016","journal-title":"Cent. Eur. J. Urol."},{"issue":"1","key":"10.1016\/j.taap.2024.117120_bb0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/iju.13985","article-title":"Pathophysiology of interstitial cystitis","volume":"26","author":"Birder","year":"2019","journal-title":"Int. J. Urol."},{"issue":"8","key":"10.1016\/j.taap.2024.117120_bb0065","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/nau.21180","article-title":"Functional characterization of a chronic cyclophosphamide-induced overactive bladder model in mice","volume":"30","author":"Boudes","year":"2011","journal-title":"Neurourol.Urodyn."},{"key":"10.1016\/j.taap.2024.117120_bb0070","first-page":"57524","article-title":"Evaluating vascular hyperpermeability-inducing agents in the skin with the miles assay","volume":"136","author":"Brash","year":"2018","journal-title":"J. Visual. Exp."},{"issue":"7","key":"10.1016\/j.taap.2024.117120_bb0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41585-022-00602-4","article-title":"Immunomodulation therapy offers new molecular strategies to treat UTI","volume":"19","author":"Butler","year":"2022","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.taap.2024.117120_bb0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/JU.0000000000002756","article-title":"Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome","volume":"208","author":"Clemens","year":"2022","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.taap.2024.117120_bb0085","doi-asserted-by":"crossref","first-page":"F90","DOI":"10.1152\/ajprenal.00017.2019","article-title":"Cystitis-induced bladder pain is toll-like receptor 4 dependent in a transgenic autoimmune cystitis murine model: a MAPP research network animal study","volume":"317","author":"Cui","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.taap.2024.117120_bb0090","doi-asserted-by":"crossref","first-page":"F460","DOI":"10.1152\/ajprenal.00100.2018","article-title":"Deletion or pharmacological blockade of TLR4 confers protection against cyclophosphamide-induced mouse cystitis","volume":"315","author":"de Oliveira","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.taap.2024.117120_bb0095","doi-asserted-by":"crossref","first-page":"592","DOI":"10.5604\/17322693.1009703","article-title":"Bladder urotoxicity pathophysiology induced by the oxazaphosphorine alkylating agents and its chemoprevention","volume":"66","author":"Dobrek","year":"2012","journal-title":"Postepy Hig. Med. Dosw."},{"key":"10.1016\/j.taap.2024.117120_bb0100","series-title":"Cystitis - Updates and Challenges","article-title":"Drug-related cystitis: An overview","author":"Engin","year":"2023"},{"issue":"6","key":"10.1016\/j.taap.2024.117120_bb0105","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00210-021-02055-9","article-title":"Double benefit of metformin treatment: improved bladder function in cyclophosphamide-induced cystitis and enhanced cytotoxicity in cancer cells","volume":"394","author":"Engin","year":"2021","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.taap.2024.117120_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120590","article-title":"Trimetazidine attenuates cyclophosphamide-induced cystitis by inhibiting TLR4-mediated NF\u03baB signaling in mice","volume":"301","author":"Engin","year":"2022","journal-title":"Life Sci."},{"issue":"8\u20139","key":"10.1016\/j.taap.2024.117120_bb0115","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.phymed.2012.04.006","article-title":"Effect of silymarin on bladder overactivity in cyclophosphamide-induced cystitis rat model","volume":"19","author":"Eser","year":"2012","journal-title":"Phytomedicine"},{"issue":"Suppl. 1","key":"10.1016\/j.taap.2024.117120_bb0120","first-page":"16","article-title":"Treatment approaches for interstitial cystitis: multimodality therapy","volume":"4","author":"Evans","year":"2002","journal-title":"Rev. Urol."},{"issue":"12","key":"10.1016\/j.taap.2024.117120_bb0125","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1007\/s11255-023-03726-7","article-title":"Serpina3n\/serpina3 alleviates cyclophosphamide-induced interstitial cystitis by activating the Wnt\/\u03b2-catenin signal","volume":"55","author":"Fang","year":"2023","journal-title":"Int. Urol. Nephrol."},{"issue":"9","key":"10.1016\/j.taap.2024.117120_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001109","article-title":"Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection","volume":"6","author":"Fischer","year":"2010","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.taap.2024.117120_bb0135","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12974-018-1098-4","article-title":"Cellular and behavioral effects of lipopolysaccharide treatment are dependent upon neurokinin-1 receptor activation","volume":"15","author":"Fulenwider","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"14","key":"10.1016\/j.taap.2024.117120_bb0140","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s40265-016-0627-7","article-title":"Fosaprepitant Dimeglumine: a review in the prevention of nausea and vomiting associated with chemotherapy","volume":"76","author":"Garnock-Jones","year":"2016","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.taap.2024.117120_bb0145","first-page":"35","article-title":"An update on treatment options for interstitial cystitis","volume":"19","author":"Garzon","year":"2020","journal-title":"Prz Menopauzalny."},{"issue":"3","key":"10.1016\/j.taap.2024.117120_bb0150","article-title":"The mouse cyclophosphamide model of bladder pain syndrome: tissue characterization, immune profiling, and relationship to metabotropic glutamate receptors","volume":"2","author":"Golubeva","year":"2014","journal-title":"Phys. Rep."},{"key":"10.1016\/j.taap.2024.117120_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104724","article-title":"Urinary bladder sigma-1 receptors: a new target for cystitis treatment","volume":"155","author":"Gonz\u00e1lez-Cano","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.taap.2024.117120_bb0160","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ebiom.2014.10.011","article-title":"Inhibition of Cyclooxygenase-2 prevents chronic and recurrent cystitis","volume":"1","author":"Hannan","year":"2014","journal-title":"EBioMedicine"},{"key":"10.1016\/j.taap.2024.117120_bb0165","article-title":"Neurokinin-1 receptor antagonist treatment in polymicrobial sepsis: molecular insights","volume":"2010","author":"Hegde","year":"2010","journal-title":"Int. J. Inflamm."},{"issue":"1","key":"10.1016\/j.taap.2024.117120_bb0170","doi-asserted-by":"crossref","first-page":"430","DOI":"10.18632\/oncotarget.13440","article-title":"Targeting tachykinin receptors in neuroblastoma","volume":"8","author":"Henssen","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.taap.2024.117120_bb0175","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.urology.2011.12.053","article-title":"Suicidal ideation among patients with bladder pain syndrome\/interstitial cystitis","volume":"80","author":"Hepner","year":"2012","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.taap.2024.117120_bb0180","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1152\/ajprenal.00297.2013","article-title":"Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation","volume":"306","author":"Hughes","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"10.1016\/j.taap.2024.117120_bb0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/019021401459752","article-title":"Influence of neuropeptides on neutrophil adhesion and transmigration through a lung fibroblast barrier in vitro","volume":"27","author":"K\u00e4hler","year":"2001","journal-title":"Exp. Lung Res."},{"issue":"5","key":"10.1016\/j.taap.2024.117120_bb0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.taap.2024.117120_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.903834","article-title":"The NLRP3 Inflammasome inhibitor Dapansutrile attenuates cyclophosphamide-induced interstitial cystitis","volume":"13","author":"Kiran","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.taap.2024.117120_bb0200","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2017.01.021","article-title":"Substance P represents a novel first-line defense mechanism in the nose","volume":"141","author":"Larsson","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.taap.2024.117120_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108825","article-title":"Topical neurokinin-1 receptor antagonist Fosaprepitant ameliorates ocular graft-versus-host disease in a preclinical mouse model","volume":"212","author":"Lasagni Vitar","year":"2021","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.taap.2024.117120_bb0210","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1038\/s41598-022-09155-3","article-title":"Role of detrusor PDGFR\u03b1+ cells in mouse model of cyclophosphamide-induced detrusor overactivity","volume":"12","author":"Lee","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.taap.2024.117120_bb0215","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s10753-018-0888-2","article-title":"The effects of neurokinin-1 receptor antagonist in an experimental autoimmune cystitis model resembling bladder pain syndrome\/interstitial cystitis","volume":"42","author":"Liu","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.taap.2024.117120_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117590","article-title":"Chlorogenic acid attenuates cyclophosphamide-induced rat interstitial cystitis","volume":"254","author":"Luo","year":"2020","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.taap.2024.117120_bb0225","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1464-410X.1998.00507.x","article-title":"Increased expression of substance P receptor-encoding mRNA in bladder biopsies from patients with interstitial cystitis","volume":"81","author":"Marchand","year":"1998","journal-title":"Br. J. Urol."},{"issue":"2","key":"10.1016\/j.taap.2024.117120_bb0230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-0038-1676089","article-title":"Interstitial cystitis\/bladder pain syndrome","volume":"36","author":"Marcu","year":"2018","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.taap.2024.117120_bb0235","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.crimmu.2021.06.001","article-title":"Neurokinin receptors and their implications in various autoimmune diseases","volume":"2","author":"Mishra","year":"2021","journal-title":"Curr. Res. Immunol."},{"issue":"9","key":"10.1016\/j.taap.2024.117120_bb0240","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3390\/cancers12092682","article-title":"The Neurokinin-1 receptor antagonist Aprepitant: an intelligent bullet against cancer?","volume":"12","author":"Mu\u00f1oz","year":"2020","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.taap.2024.117120_bb0245","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3892\/ijo.2014.2565","article-title":"The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer","volume":"45","author":"Mu\u00f1oz","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.taap.2024.117120_bb0250","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.expneurol.2011.09.038","article-title":"Toll-like receptors in chronic pain","volume":"234","author":"Nicotra","year":"2012","journal-title":"Exp. Neurol."},{"issue":"23","key":"10.1016\/j.taap.2024.117120_bb0255","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.lfs.2013.10.010","article-title":"High-dose tranilast administration to rats creates interstitial cystitis-like symptoms with increased vascular permeability","volume":"93","author":"Nishijima","year":"2013","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.taap.2024.117120_bb0260","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101025R","article-title":"Absence of prostacyclin greatly relieves cyclophosphamide-induced cystitis and bladder pain in mice","volume":"35","author":"Ochiai","year":"2021","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.taap.2024.117120_bb0265","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12818","article-title":"Toll-like receptors: the role in bladder cancer development, progression and immunotherapy","volume":"90","author":"Ohadian Moghadam","year":"2019","journal-title":"Scand. J. Immunol."},{"issue":"4","key":"10.1016\/j.taap.2024.117120_bb0270","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/1440-1681.12875","article-title":"Involvement of NF-\u03baB in the upregulation of cystathionine-\u03b3-lyase, a hydrogen sulfide-forming enzyme, and bladder pain accompanying cystitis in mice","volume":"45","author":"Ozaki","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.taap.2024.117120_bb0275","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fphar.2016.00234","article-title":"Netupitant, a potent and highly selective NK1 receptor antagonist, alleviates acetic acid-induced bladder overactivity in anesthetized guinea-pigs","volume":"7","author":"Palea","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2024.117120_bb0280","first-page":"73","article-title":"Endogenous tachykinins play a role in IL-1-induced neutrophil accumulation: involvement of NK-1 receptors","volume":"80","author":"Perretti","year":"1993","journal-title":"Immunology"},{"key":"10.1016\/j.taap.2024.117120_bb0285","article-title":"An in vivo assay to test blood vessel permeability","volume":"73","author":"Radu","year":"2013","journal-title":"J. Visual. Exp."},{"key":"10.1016\/j.taap.2024.117120_bb0290","article-title":"Topical fosaprepitant for the treatment of ocular pain and inflammation","volume":"32","author":"Suanno","year":"2023","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"10.1016\/j.taap.2024.117120_bb0295","doi-asserted-by":"crossref","first-page":"1232017","DOI":"10.3389\/fphys.2023.1232017","article-title":"Animal models of interstitial cystitis\/bladder pain syndrome","volume":"14","author":"Tay","year":"2023","journal-title":"Front. Physiol."},{"issue":"9","key":"10.1016\/j.taap.2024.117120_bb0300","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1440-1681.2004.04061.x","article-title":"Interactions of tachykinin receptor antagonists with lipopolysaccharide-induced airway inflammation in mice","volume":"31","author":"Veron","year":"2004","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"2","key":"10.1016\/j.taap.2024.117120_bb0305","first-page":"430","article-title":"Tachykinin-1 receptor stimulates proinflammatory gene expression in lung epithelial cells through activation of NF-kappaB via a G(q)-dependent pathway","volume":"292","author":"Williams","year":"2007","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.taap.2024.117120_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173321","article-title":"The effect of O-1602, a GPR55 agonist, on the cyclophosphamide-induced rat hemorrhagic cystitis","volume":"882","author":"Wr\u00f3bel","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.taap.2024.117120_bb0315","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.3390\/ijms22115853","article-title":"The potential of asiatic acid in the reversion of cyclophosphamide-induced hemorrhagic cystitis in rats","volume":"22","author":"Wr\u00f3bel","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.taap.2024.117120_bb0320","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/nau.25415","article-title":"The effects of a galectin-3 inhibitor on bladder pain syndrome in mice with cyclophosphamide-induced cystitis","volume":"43","author":"Xiao","year":"2024","journal-title":"Neurourol.Urodyn."},{"issue":"5","key":"10.1016\/j.taap.2024.117120_bb0325","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1128\/IAI.73.5.2940-2950.2005","article-title":"Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins","volume":"73","author":"Zughaier","year":"2005","journal-title":"Infect. Immun."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24003193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24003193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T09:12:09Z","timestamp":1731402729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X24003193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":65,"alternative-id":["S0041008X24003193"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2024.117120","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fosaprepitant improves cyclophosphamide-induced bladder damage by alleviating inflammatory response in mice","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2024.117120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117120"}}